A new study from Imperial College London suggests that millions of healthy individuals could benefit from taking low-dose statins to reduce their risk of heart attacks and strokes. The research, which analyzed data from 17 clinical trials involving over 100,000 participants, found that even a small reduction in LDL (low-density lipoprotein) cholesterol in people deemed at low risk for cardiovascular events within the next decade cut their risk by 25 percent.
Earlier Intervention Key
Dr. Irene Karungi from the School of Public Health at Imperial College London explained: "Our analysis shows the benefit of reducing LDL in people who are at low risk is much greater than waiting until they might become high risk. Once disease is established, treatment has to be much more intensive."
Current NHS guidelines typically prescribe statins only after patients begin experiencing health problems related to high cholesterol. However, specialists argue that this research supports changing the rules to allow earlier prescription of the drug. "You would need a smaller dose of statins to get the same effect," added Dr. Karungi.
Reducing Future Heart Disease Burden
The findings, presented at the European Atherosclerosis Society Congress in Athens, Greece, could help curb the rising number of heart disease diagnoses. Currently, over seven million people in the UK take cholesterol-lowering medications. By 2040, the number expected to be diagnosed with cardiovascular disease is projected to reach 10 million.
Study author Professor Kausik Ray, a public health expert, drew an analogy: "It's like a pension scheme – the earlier you start, the bigger the long-term benefits."
